Hibiscus Petroleum BHD (5199)
Bursa Malaysia · Malaysia · prices in MYR · close of 27 Oct 2026
Key indicators
| Last close | MYR 2.420 |
|---|---|
| 52-week range | 1.400 – 2.470 |
| Return, 1 month / 3 months | +8.5% / +23.3% |
| Return, 1 year / 3 years | +73.4% / +2.5% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 47.5% |
| Worst drawdown (1 year) | -24.8% |
| Average daily value traded | 10.56M MYR |
| Dividend yield | 3.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hibiscus Petroleum is an independent oil and gas company based in Malaysia. It explores for, develops and produces crude oil and natural gas from fields offshore Malaysia and in the United Kingdom, and it also holds interests in other producing and development assets. Its customers are the buyers of its crude oil and gas output, and its operations are run through subsidiaries and joint ventures with partners in the regions where it works.
The shares are listed on the Bursa Malaysia in Malaysia under the code 5199, and the price on this page is in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hibiscus Petroleum BHD (5199) trades on the Bursa Malaysia in Malaysia. It last closed at MYR 2.420 on 27 October 2026.
Its price-based Market X-Ray is 78 out of 100 (a strong price profile), ranking 58 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 73.4% and over the last three months it rose 23.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bursa Malaysia
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 23.4% | ||
| From 52-week high | -0.4% | ||
| Momentum | 89 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 23.3% | ||
| 6-month return | 16.6% | ||
| 12-month return, skipping the last month | 59.7% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 47.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.8% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 10.56M MYR | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.1% |
|---|---|
| 1 month | +8.5% |
| 3 months | +23.3% |
| 6 months | +16.6% |
| 1 year | +73.4% |
| 3 years | +2.5% |
| 5 years | +26.5% |
Signals
| 50-day / 200-day average | 2.215 / 1.961 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.081 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Sep 2026 | MYR 0.0200 |
| 18 Jun 2026 | MYR 0.0300 |
| 25 Mar 2026 | MYR 0.0200 |
| 31 Dec 2025 | MYR 0.0050 |
| 26 Dec 2025 | MYR 0.0200 |
| 25 Sep 2025 | MYR 0.0050 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bursa Malaysia; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.